These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36530328)

  • 21. Osthole induces cell cycle arrest and apoptosis in head and neck squamous cell carcinoma by suppressing the PI3K/AKT signaling pathway.
    Yang J; Zhu XJ; Jin MZ; Cao ZW; Ren YY; Gu ZW
    Chem Biol Interact; 2020 Jan; 316():108934. PubMed ID: 31870840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amphipathic barbiturates as marine product mimics with cytolytic and immunogenic effects on head and neck squamous cell carcinoma cell lines.
    von Hofsten S; Langer MK; Korelin K; Magnussen S; Ausbacher D; Anderssen T; Salo T; Strøm MB; Bayer A; Al-Samadi A; Berge G
    Front Pharmacol; 2023; 14():1141669. PubMed ID: 37063262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cellular uptake and anticancer activity of salvianolic acid B phospholipid complex loaded nanoparticles in head and neck cancer and precancer cells.
    Li H; Shi L; Wei J; Zhang C; Zhou Z; Wu L; Liu W
    Colloids Surf B Biointerfaces; 2016 Nov; 147():65-72. PubMed ID: 27490455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytotoxic and Apoptotic Effects of Novel Pyrrolo[2,3-d]Pyrimidine Derivatives Containing Urea Moieties on Cancer Cell Lines.
    Kilic-Kurt Z; Bakar-Ates F; Karakas B; Kütük Ö
    Anticancer Agents Med Chem; 2018; 18(9):1303-1312. PubMed ID: 29866023
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A combination of a ribonucleotide reductase inhibitor and histone deacetylase inhibitors downregulates EGFR and triggers BIM-dependent apoptosis in head and neck cancer.
    Stauber RH; Knauer SK; Habtemichael N; Bier C; Unruhe B; Weisheit S; Spange S; Nonnenmacher F; Fetz V; Ginter T; Reichardt S; Liebmann C; Schneider G; Krämer OH
    Oncotarget; 2012 Jan; 3(1):31-43. PubMed ID: 22289787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Flavopiridol, a novel cyclin-dependent kinase inhibitor, suppresses the growth of head and neck squamous cell carcinomas by inducing apoptosis.
    Patel V; Senderowicz AM; Pinto D; Igishi T; Raffeld M; Quintanilla-Martinez L; Ensley JF; Sausville EA; Gutkind JS
    J Clin Invest; 1998 Nov; 102(9):1674-81. PubMed ID: 9802881
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blocking of stromal interaction molecule 1 expression influence cell proliferation and promote cell apoptosis in vitro and inhibit tumor growth in vivo in head and neck squamous cell carcinoma.
    Li P; Bian XY; Chen Q; Yao XF; Wang XD; Zhang WC; Tao YJ; Jin R; Zhang L
    PLoS One; 2017; 12(5):e0177484. PubMed ID: 28494008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Nedd8-activating enzyme inhibitor MLN4924 (TAK-924/Pevonedistat) induces apoptosis via c-Myc-Noxa axis in head and neck squamous cell carcinoma.
    Zhang W; Liang Y; Li L; Wang X; Yan Z; Dong C; Zeng MS; Zhong Q; Liu XK; Yu J; Sun S; Liu X; Kang J; Zhao H; Jeong LS; Zhang Y; Jia L
    Cell Prolif; 2019 Mar; 52(2):e12536. PubMed ID: 30341788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single-agent obatoclax (GX15-070) potently induces apoptosis and pro-survival autophagy in head and neck squamous cell carcinoma cells.
    Yazbeck VY; Li C; Grandis JR; Zang Y; Johnson DE
    Oral Oncol; 2014 Feb; 50(2):120-7. PubMed ID: 24216166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis, Anticancer Assessment, and Molecular Docking of Novel Chalcone-Thienopyrimidine Derivatives in HepG2 and MCF-7 Cell Lines.
    Safwat GM; Hassanin KMA; Mohammed ET; Ahmed EK; Abdel Rheim MR; Ameen MA; Abdel-Aziz M; Gouda AM; Peluso I; Almeer R; Abdel-Daim MM; Abdel-Wahab A
    Oxid Med Cell Longev; 2021; 2021():4759821. PubMed ID: 35003514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Verteporfin suppresses the proliferation, epithelial-mesenchymal transition and stemness of head and neck squamous carcinoma cells via inhibiting YAP1.
    Liu K; Du S; Gao P; Zheng J
    J Cancer; 2019; 10(18):4196-4207. PubMed ID: 31413738
    [No Abstract]   [Full Text] [Related]  

  • 32. Immune checkpoint inhibitors in head and neck squamous cell carcinoma: A systematic review of phase-3 clinical trials.
    Poulose JV; Kainickal CT
    World J Clin Oncol; 2022 May; 13(5):388-411. PubMed ID: 35662989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Smac modulates chemosensitivity in head and neck cancer cells through the mitochondrial apoptotic pathway.
    Sun Q; Zheng X; Zhang L; Yu J
    Clin Cancer Res; 2011 Apr; 17(8):2361-72. PubMed ID: 21242120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radioimmunotherapy of experimental head and neck squamous cell carcinoma (HNSCC) with E6-specific antibody using a novel HPV-16 positive HNSCC cell line.
    Harris M; Wang XG; Jiang Z; Goldberg GL; Casadevall A; Dadachova E
    Head Neck Oncol; 2011 Feb; 3(1):9. PubMed ID: 21314983
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EGFR/VEGFR-2 dual inhibitor and apoptotic inducer: Design, synthesis, anticancer activity and docking study of new 2-thioxoimidazolidin-4one derivatives.
    Mourad AAE; Farouk NA; El-Sayed EH; Mahdy ARE
    Life Sci; 2021 Jul; 277():119531. PubMed ID: 33887348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antitumor Efficacy of EGFR-Targeted Recombinant Immunotoxin in Human Head and Neck Squamous Cell Carcinoma.
    Xie G; Shan L; Liu Y; Wu TC; Gu X
    Biology (Basel); 2022 Mar; 11(4):. PubMed ID: 35453686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. pH-responsive nanoprodrugs combining a Src inhibitor and chemotherapy to potentiate antitumor immunity via pyroptosis in head and neck cancer.
    Zhu SW; Ye M; Ma X; Wu ZZ; Wan SC; Yang SC; Li H; Xu Z; Sun ZJ
    Acta Biomater; 2022 Dec; 154():497-509. PubMed ID: 36367476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ON 01910.Na (rigosertib) inhibits PI3K/Akt pathway and activates oxidative stress signals in head and neck cancer cell lines.
    Prasad A; Khudaynazar N; Tantravahi RV; Gillum AM; Hoffman BS
    Oncotarget; 2016 Nov; 7(48):79388-79400. PubMed ID: 27764820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Calprotectin and the Initiation and Progression of Head and Neck Cancer.
    Argyris PP; Slama ZM; Ross KF; Khammanivong A; Herzberg MC
    J Dent Res; 2018 Jun; 97(6):674-682. PubMed ID: 29443623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of Focal Adhesion Kinase in Head and Neck Squamous Cell Carcinoma and Its Therapeutic Prospect.
    Zhang Y; Sun X
    Onco Targets Ther; 2020; 13():10207-10220. PubMed ID: 33116602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.